Jamila Aboulhab

447 total citations
9 papers, 299 citations indexed

About

Jamila Aboulhab is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jamila Aboulhab has authored 9 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Jamila Aboulhab's work include HIV Research and Treatment (3 papers), Viral Infections and Outbreaks Research (3 papers) and Disaster Response and Management (3 papers). Jamila Aboulhab is often cited by papers focused on HIV Research and Treatment (3 papers), Viral Infections and Outbreaks Research (3 papers) and Disaster Response and Management (3 papers). Jamila Aboulhab collaborates with scholars based in Singapore, Guinea and United States. Jamila Aboulhab's co-authors include Nicholas I. Paton, Nicholas I. Paton, Arul Earnest, Moussa Keïta, S. Patrick Kachur, Mateusz M. Pluciński, Eric S. Halsey, Ian Hennessee, Peter D. McElroy and Sidikiba Sidibé and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Jamila Aboulhab

9 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jamila Aboulhab Singapore	7	198	61	54	52	46	9	299
Mohamed Cissé Guinea	12	268 1.4×	132 2.2×	27 0.5×	12 0.2×	64 1.4×	64	414
Sumonmal Uttayamakul Thailand	10	329 1.7×	107 1.8×	58 1.1×	23 0.4×	112 2.4×	22	495
James G. Carlucci United States	10	217 1.1×	42 0.7×	62 1.1×	29 0.6×	145 3.2×	36	394
Candice Ruck Canada	9	116 0.6×	64 1.0×	9 0.2×	34 0.7×	118 2.6×	13	314
JM Gatell Spain	9	231 1.2×	166 2.7×	18 0.3×	138 2.7×	177 3.8×	15	410
H.R. Brodt Germany	10	100 0.5×	28 0.5×	45 0.8×	33 0.6×	111 2.4×	14	259
Matthias L. Schmid United Kingdom	10	118 0.6×	35 0.6×	79 1.5×	8 0.2×	64 1.4×	15	278
Jordan Cates United States	10	233 1.2×	13 0.2×	50 0.9×	18 0.3×	62 1.3×	24	337
Padmamohan J. Kurup Oman	9	104 0.5×	8 0.1×	32 0.6×	13 0.3×	62 1.3×	21	300
Kajal Chhaganlal Italy	11	141 0.7×	10 0.2×	83 1.5×	28 0.5×	99 2.2×	22	332

Countries citing papers authored by Jamila Aboulhab

Since Specialization

Citations

This map shows the geographic impact of Jamila Aboulhab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamila Aboulhab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamila Aboulhab more than expected).

Fields of papers citing papers by Jamila Aboulhab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamila Aboulhab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamila Aboulhab. The network helps show where Jamila Aboulhab may publish in the future.

Co-authorship network of co-authors of Jamila Aboulhab

This figure shows the co-authorship network connecting the top 25 collaborators of Jamila Aboulhab. A scholar is included among the top collaborators of Jamila Aboulhab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamila Aboulhab. Jamila Aboulhab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Higgs, Elizabeth S., William A. Fischer, Martha Nason, et al.. (2021). PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors. Clinical Infectious Diseases. 73(10). 1849–1856. 24 indexed citations

Béavogui, Abdoul Habib, Alexandre Délamou, Mandy Kader Kondé, et al.. (2016). Clinical research during the Ebola virus disease outbreak in Guinea: Lessons learned and ways forward. Clinical Trials. 13(1). 73–78. 12 indexed citations

Pluciński, Mateusz M., Timothée Guilavogui, Sidikiba Sidibé, et al.. (2015). Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities. The Lancet Infectious Diseases. 15(9). 1017–1023. 104 indexed citations

Edeghere, Obaghe, et al.. (2015). Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health. 129(5). 509–516. 2 indexed citations

Aboulhab, Jamila. (2006). HBV viral load is an independent predictor of progression to hepatocellular carcinoma in chronic HBV patients. Weekly releases (1997–2007). 11(4). E060126.6–E060126.6. 3 indexed citations

Aboulhab, Jamila, et al.. (2005). Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV‐infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks. HIV Medicine. 6(1). 13–20. 43 indexed citations

Paton, Nicholas I., et al.. (2002). Lipodystrophy in a Cohort of Human Immunodeficiency Virus–Infected Asian Patients: Prevalence, Associated Factors, and Psychological Impact. Clinical Infectious Diseases. 35(10). 1244–1249. 42 indexed citations

Paton, Nicholas I., et al.. (2002). Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. The Lancet. 359(9318). 1667–1668. 40 indexed citations

Paton, Nicholas I., Siew‐Pang Chan, Karen Tan, et al.. (2002). Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV-infected patients in Singapore. International Journal of STD & AIDS. 13(7). 456–461. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact